Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel [PDF]
H. Gerding +5 more
openalex +1 more source
Eric Nudleman,1 Jeremy D Wolfe,2,3 Maria A Woodward,4 Yoshihiro Yonekawa,2,3 George A Williams,2,3 Tarek S Hassan2,3 1Department of Ophthalmology, Shiley Eye Center, University of California, San Diego, La Jolla, CA, 2Beaumont Eye Institute, Oakland ...
Nudleman E +5 more
doaj
U.S. trends of anti-vascular endothelial growth factor use from 2017-2023: An analysis of medicare, medicaid, and commercial insurance. [PDF]
Malhotra K +4 more
europepmc +1 more source
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study [PDF]
Jennifer Arnold +3 more
openalex +1 more source
Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study. [PDF]
Song JR +11 more
europepmc +1 more source
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series [PDF]
Zhongjing Lin +4 more
openalex +1 more source
Alpha-Gal Syndrome Allergy to Intravitreal Administration of Anti-Vascular Endothelial Growth Factor Agents. [PDF]
Zhang E, Bylund R, Zhang A, Massop D.
europepmc +1 more source
Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab [PDF]
Tatsuya Yoshitake +5 more
openalex +1 more source
The Effect of Intravitreal Ranibizumab Injection on Retinal Nerve Fiber Layer Thickness and Optic Disc Parameters. [PDF]
Ongun GT, Yağcı R.
europepmc +1 more source

